South Korea: New COVID-19 cases hit 266853 in one single day
- Engineered Soybeans with Pig Protein: A Promising Alternative or Pandora’s Dish?
- Severe Fever with Thrombocytopenia Syndrome (SFTS): A Tick-Borne Threat with High Mortality
- Why Isolating Bananas Extends Their Shelf Life?
- This common vitamin benefits the brain and prevents cognitive decline
- New report reveals Nestlé adding sugar to infant formula sold in poor countries
- Did Cloud Seeding Unleash a Deluge in Dubai?
South Korea: New COVID-19 cases hit 266853 in one single day
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
South Korea: New COVID-19 cases hit 266,853 in one single day.
With the rapid spread of the Omicron strain in South Korea, as of 0:00 on March 4, South Korea had 266,853 new confirmed cases of COVID-19, 186 new deaths, and 797 severe patients.
The number of confirmed cases and deaths in a single day has reached a new high.
Earlier, South Korean epidemic prevention authorities predicted that the peak of the current round of epidemics will be reached in early or mid-March, with up to 350,000 confirmed cases.
According to a report by Yonhap News Agency on the 3rd, South Korean primary and secondary schools were tragic as soon as they started school-all kinds of kindergartens, primary schools, and middle schools in South Korea opened on the 2nd. On the same day, 29 schools in Seoul had confirmed cases.
The South Korean government announced in the early morning of the 3rd that 6,240 students in the Seoul area were diagnosed. Among them, primary school students have the most confirmed cases, with 3,228 cases.
Not only that, the South Korean epidemic prevention commander and Prime Minister Kim Fu-gyeom was also diagnosed with the COVID-19 virus on the 3rd.
“Korea Economy” reported on the 3rd that during the week from the 3rd to the 9th, Kim Fuqian will be treated at home at the Prime Minister’s residence, and all official activities that require face-to-face will be cancelled.
High-ranking government officials including Kim Fu-gyeom have been diagnosed one after another, making South Korean senior civil servants “restless”.
The number of confirmed cases has surged, but the drugs to treat the COVID-19 are not available.
South Korea’s “Central Daily” said on the 3rd that with the opening of schools in South Korea and the South Korean government’s continued relaxation of epidemic prevention and control measures from the 1st, the number of confirmed cases in South Korea has accelerated.
Vaccines and therapeutic drugs are the two major weapons to deal with the COVID-19 virus. With the cumulative vaccination rate of South Korea reaching 87.4%, it is particularly important to successfully provide therapeutic drugs in the early stage of infection to prevent the disease from becoming severe.
However, the stock of South Korean therapeutic drug Pfizer Paxlovid and injection drug Remdesivir for critically ill patients is seriously insufficient.
Because the therapeutic drugs cannot be supplied in time, many confirmed patients have missed the best treatment period.
The number of Paxlovid in the purchase contract signed by the South Korean government and Pfizer was 762,000, but as of the 27th of last month, only 73,000 had come.
The number of home-treated patients in South Korea is about to reach 1 million, but the prescription and delivery services of community hospitals are not guaranteed.
Many confirmed patients cannot obtain treatment drugs and can only rely on antipyretics to barely survive.
With the rapid spread of the Omicron strain in South Korea, as of 0:00 on March 4, South Korea had 266,853 new confirmed cases of COVID-19, 186 new deaths, and 797 severe patients. The number of confirmed cases and deaths in a single day has reached a new high.
Earlier, South Korean epidemic prevention authorities predicted that the peak of the current round of epidemics will be reached in early or mid-March, with up to 350,000 confirmed cases.
According to a report by Yonhap News Agency on the 3rd, South Korean primary and secondary schools were tragic as soon as they started school-all kinds of kindergartens, primary schools, and middle schools in South Korea opened on the 2nd.
On the same day, 29 schools in Seoul had confirmed cases. The South Korean government announced in the early morning of the 3rd that 6,240 students in the Seoul area were diagnosed.
Among them, primary school students have the most confirmed cases, with 3,228 cases. Not only that, the South Korean epidemic prevention commander and Prime Minister Kim Fu-gyeom was also diagnosed with the COVID-19 virus on the 3rd.
“Korea Economy” reported on the 3rd that during the week from the 3rd to the 9th, Kim Fuqian will be treated at home at the Prime Minister’s residence, and all official activities that require face-to-face will be cancelled.
High-ranking government officials including Kim Fu-gyeom have been diagnosed one after another, making South Korean senior civil servants “restless”.
The number of confirmed cases has surged, but the drugs to treat the COVID-19 are not available. South Korea’s “Central Daily” said on the 3rd that with the opening of schools in South Korea and the South Korean government’s continued relaxation of epidemic prevention and control measures from the 1st, the number of confirmed cases in South Korea has accelerated. Vaccines and therapeutic drugs are the two major weapons to deal with the COVID-19 virus.
With the cumulative vaccination rate of South Korea reaching 87.4%, it is particularly important to successfully provide therapeutic drugs in the early stage of infection to prevent the disease from becoming severe.
However, the stock of South Korean therapeutic drug Pfizer Paxlovid and injection drug Remdesivir for critically ill patients is seriously insufficient. Because the therapeutic drugs cannot be supplied in time, many confirmed patients have missed the best treatment period.
The number of Paxlovid in the purchase contract signed by the South Korean government and Pfizer was 762,000, but as of the 27th of last month, only 73,000 had come. The number of home-treated patients in South Korea is about to reach 1 million, but the prescription and delivery services of community hospitals are not guaranteed.
Many confirmed patients cannot obtain treatment drugs and can only rely on antipyretics to barely survive.
South Korea: New COVID-19 cases hit 266853 in one single day
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
